Zantac / Ranitidine (NDMA Cancer) Attorney in Atlanta, Georgia

Zantac Litigation in Atlanta

Atlanta's diverse economy and large Fortune 500 corporate workforce mean many claimants have comprehensive employer pharmacy benefit records documenting ranitidine use. Georgia applies Daubert under O.C.G.A. § 24-7-702. Atlanta-area Zantac claimants should consult national plaintiffs' counsel about Delaware Superior Court — where Judge Medinilla has allowed Zantac causation experts to proceed — as the primary filing venue. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Atlanta Zantac Claimants

Atlanta-area Zantac claimants should gather pharmacy records from Kroger, CVS, Walgreens, and employer pharmacy benefit programs for Delta, Home Depot, and other large Atlanta employers. Winship Cancer Institute at Emory and Piedmont records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. Georgia's 2-year SOL requires prompt legal consultation.